Home A comprehensive comparison between ISAC and ALEX2 multiplex test systems
Article
Licensed
Unlicensed Requires Authentication

A comprehensive comparison between ISAC and ALEX2 multiplex test systems

  • Anouk C.M. Platteel , Pieter van der Pol , Jean-Luc Murk , Ingrid Verbrugge-Bakker , Marian Hack-Steemers , Theo H.W.M. Roovers and Michiel Heron ORCID logo EMAIL logo
Published/Copyright: April 27, 2022

Abstract

Objectives

Diagnosis of type I hypersensitivity is based on anamnesis, provocation as well as blood- and skin testing. Multiplex specific IgE (sIgE) testing enables determination of sIgE antibodies against multiple recombinant or purified natural allergen components. The aim of this study was to evaluate the performance of the novel ALEX (Allergy Explorer, ALEX2 test introduced on the market November 2019) multiplex platform and to compare it with the ImmunoCAP ISAC® test system.

Methods

Serum samples of 49 patients, routinely determined with ISAC, were selected based on positive results covering in total most of the 112 ISAC components. Cohen’s kappa, negative percent agreement (NPA), and positive percent agreement (PPA) of ALEX2 data compared to ISAC data (as a non-reference standard) were computed for those allergen components present on both platforms (n=103). Furthermore, in some samples sIgE results against allergen extracts and/or -components tested with either ImmunoCAP® (ThermoFisher) or IMMULITE® (Siemens) were available and compared to ALEX2 results.

Results

The overall agreement between ISAC and ALEX2 common allergen components was 94%. NPA and PPA were respectively 95 and 90%. Kappa values differed for specific allergen groups and varied between 0.60 and 0.92 showing moderate to almost perfect agreement. Of the qualitative discrepancies between ALEX2 and ISAC, 59% were related to weak positive results i.e. results under 1 kUA/L or 1 ISU, respectively.

Conclusions

The method comparison between ISAC and ALEX2 multiplex tests showed a high concordance for those allergen components present on both platforms.


Corresponding author: Michiel Heron, Medical Microbiology and Immunology, Diakonessenhuis, Bosboomstraat 1, Utrecht, Netherlands, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The local Institutional Review Board deemed the study exempt from review.

References

1. Kowalski, ML, Ansotegui, I, Aberer, W, Al-Ahmad, M, Akdis, M, Ballmer-Weber, BK, et al.. Risk and safety requirements for diagnostic and therapeutic procedures in allergology: world allergy organization statement. World Allergy Organ J 2016;9:1–42. https://doi.org/10.1186/s40413-016-0122-3.Search in Google Scholar PubMed PubMed Central

2. Canonica, GW, Ansotegui, IJ, Pawankar, R, Schmid-Grendelmeier, P, van Hage, M, Baena-Cagnani, CE, et al.. A WAO - ARIA - GA(2)LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J 2013;6:4517–51. https://doi.org/10.1186/1939-4551-6-17.Search in Google Scholar PubMed PubMed Central

3. Passalacqua, G, Melioli, G, Bonifazi, F, Bonini, S, Maggi, E, Senna, G, et al.. The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy. Allergy 2013;68:1029–33. https://doi.org/10.1111/all.12194.Search in Google Scholar PubMed

4. Bojcukova, J, Vlas, T, Forstenlechner, P, Panzner, P. Comparison of two multiplex arrays in the diagnostics of allergy. Clin Transl Allergy 2019;9:31. https://doi.org/10.1186/s13601-019-0270-y.Search in Google Scholar

5. Scala, E, Caprini, E, Abeni, D, Meneguzzi, G, Buzzulini, F, Cecchi, L, et al.. A qualitative and quantitative comparison of IgE antibody profiles with two multiplex platforms for component-resolved diagnostics in allergic patients. Clin Exp Allergy 2021;51:1603–12. https://doi.org/10.1111/cea.14016.Search in Google Scholar PubMed

6. Heffler, E, Puggioni, F, Peveri, S, Montagni, M, Canonica, GW, Melioli, G. Extended IgE profile based on an allergen macroarray: a novel tool for precision medicine in allergy diagnosis. World Allergy Organ J 2018;11:07–18. https://doi.org/10.1186/s40413-018-0186-3.Search in Google Scholar PubMed PubMed Central

7. Gafvelin, G, Johansson, E, Lundin, A, Smith, AM, Chapman, MD, Benjamin, DC, et al.. Cross-reactivity studies of a new group 2 allergen from the dust mite glycyphagus domesticus, Gly d 2, and group 2 allergens from dermatophagoides pteronyssinus, lepidoglyphus destructor, and tyrophagus putrescentiae with recombinant allergens. J Allergy Clin Immunol 2001;107:511–8. https://doi.org/10.1067/mai.2001.112264.Search in Google Scholar PubMed

8. Hoang, JA, Celik, A, Lupinek, C, Valenta, R, Duan, L, Dai, R, et al.. Modeling the conversion between specific IgE test platforms for nut allergens in children and adolescents. Allergy 2021;76:831–41. https://doi.org/10.1111/all.14529.Search in Google Scholar PubMed

9. Scala, E, Abeni, D, Guerra, EC, Pirrotta, L, Locanto, M, Meneguzzi, G, et al.. β-1,3-glucanase rOle e 9 and MnSOD rAsp f 6 IgE reactivity are the signature of atopic dermatitis in the mediterranean area. Clin Exp Allergy 2020;50:487–98. https://doi.org/10.1111/cea.13555.Search in Google Scholar PubMed

10. Hemmer, W, Altmann, F, Holzweber, F, Gruber, C, Wantke, F, Wohrl, S. ImmunoCAP cellulose displays cross-reactive carbohydrate determinant (CCD) epitopes and can cause false-positive test results in patients with high anti-CCD IgE antibody levels. J Allergy Clin Immunol 2018;141:372–81. https://doi.org/10.1016/j.jaci.2017.04.028.Search in Google Scholar PubMed

11. Sinson, E, Ocampo, C, Liao, C, Nguyen, S, Dinh, L, Rodems, K, et al.. Cross-reactive carbohydrate determinant interference in cellulose-based IgE allergy tests utilizing recombinant allergen components. PLoS One 2020;15:e0231344. https://doi.org/10.1371/journal.pone.0231344.Search in Google Scholar PubMed PubMed Central

12. Villalta, D, Conte, M, Asero, R, Da Re, M, Stella, S, Martelli, P. Isolated IgE reactivity to native walnut vicilin-like protein (nJug r 2) on ISAC microarray is due to cross-reactive carbohydrate epitopes. Clin Chem Lab Med 2013;51:1991–5. https://doi.org/10.1515/cclm-2013-0027.Search in Google Scholar PubMed

13. Caraballo, L, Valenta, R, Acevedo, N, Zakzuk, J. Are the terms major and minor allergens useful for precision allergology? Front Immunol 2021;12:1–4. https://doi.org/10.3389/fimmu.2021.651500.Search in Google Scholar PubMed PubMed Central

14. Griffiths, RLM, El-Shanawany, T, Jolles, SRA, Selwood, C, Heaps, AG, Carne, EM, et al.. Comparison of the performance of skin prick, ImmunoCAP, and ISAC tests in the diagnosis of patients with allergy. Int Arch Allergy Immunol 2017;172:215–23. https://doi.org/10.1159/000464326.Search in Google Scholar PubMed

15. Čelakovská, J, Bukač, J, Cermákova, E, Vaňková, R, Skalská, H, Krejsek, J, et al.. Analysis of results of specific IgE in 100 atopic dermatitis patients with the use of multiplex examination ALEX2-Allergy explorer. Int J Mol Sci 2021;22:5286–318.10.3390/ijms22105286Search in Google Scholar PubMed PubMed Central

16. Villalta, D, Scala, E, Asero, R, Da Re, M, Conte, M, Buzzulini, F. Evaluation and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens using a new multiplex assay: a real-life experience on an Italian population. Eur Ann Allergy Clin Immunol 2021;53:168–70. https://doi.org/10.23822/EurAnnACI.1764-1489.195.Search in Google Scholar PubMed

17. Pinheiro, CS, Silva, ES, de Andrade Belitardo, EMM, Pacheco, LGC, Aguiar, ERGR, Alcantara-Neves, NM, et al.. En route to personalized medicine: uncovering distinct IgE reactivity pattern to house dust mite components in Brazilian and Austrian allergic patients. Clin Transl Allergy 2021;11:e12004. https://doi.org/10.1002/clt2.12004.Search in Google Scholar PubMed PubMed Central

18. Skypala, IJ, Asero, R, Barber, D, Cecchi, L, Perales, AD, Hoffmann-Sommergruber, K, et al.. Non specific lipid-transfer proteins: allergen structure and function, cross-reactivity, sensitization, and epidemiology. Clin Transl Allergy 2021;11:e12010. https://doi.org/10.1002/clt2.12010.Search in Google Scholar PubMed PubMed Central

19. van Hage, M, Hamsten, C, Valenta, R. ImmunoCAP assays: pros and cons in allergology. J Allergy Clin Immunol 2017;140:974–7. https://doi.org/10.1016/j.jaci.2017.05.008.Search in Google Scholar PubMed

20. Buzzulini, F, Da Re, M, Scala, E, Martelli, P, Conte, M, Brusca, I, et al.. Evaluation of a new multiplex assay for allergy diagnosis. Clin Chim Acta 2019;493:73–8. https://doi.org/10.1016/j.cca.2019.02.025.Search in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2022-0191).


Received: 2022-02-28
Accepted: 2022-04-04
Published Online: 2022-04-27
Published in Print: 2022-06-27

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. The never-ending quest for antibody assays standardization and appropriate measurement units
  4. Review
  5. Glycated albumin in diabetes mellitus: a meta-analysis of diagnostic test accuracy
  6. Opinion Paper
  7. Ad interim recommendations for diagnosing SARS-CoV-2 infection by the IFCC SARS-CoV-2 variants working group
  8. Guidelines and Recommendations
  9. Recommendations for IVDR compliant in-house software development in clinical practice: a how-to paper with three use cases
  10. General Clinical Chemistry and Laboratory Medicine
  11. Comparison between polynomial regression and weighted least squares regression analysis for verification of analytical measurement range
  12. Transport stability profiling – a proposed generic protocol
  13. Impact of ultra-low temperature long-term storage on the preanalytical variability of twenty-one common biochemical analytes
  14. Development of a liquid chromatography mass spectrometry method for the determination of vitamin K1, menaquinone-4, menaquinone-7 and vitamin K1-2,3 epoxide in serum of individuals without vitamin K supplements
  15. TSH-receptor autoantibodies in patients with chronic thyroiditis and hypothyroidism
  16. Evaluation of the AFIAS-1 thyroid-stimulating hormone point of care test and comparison with laboratory-based devices
  17. Lack of analytical interference of dydrogesterone in progesterone immunoassays
  18. A comprehensive comparison between ISAC and ALEX2 multiplex test systems
  19. Detection of subarachnoid haemorrhage with spectrophotometry of cerebrospinal fluid – a comparison of two methods
  20. Importance of cerebrospinal fluid storage conditions for the Alzheimer’s disease diagnostics on an automated platform
  21. Estimating urine albumin to creatinine ratio from protein to creatinine ratio using same day measurement: validation of equations
  22. An automated, rapid fluorescent immunoassay to quantify serum soluble programmed death-1 (PD-1) protein using testing-on-a-probe biosensors
  23. Hematology and Coagulation
  24. The VES-Matic 5 system: performance of a novel instrument for measuring erythrocyte sedimentation rate
  25. Cancer Diagnostics
  26. Is thyroglobulin a reliable biomarker of differentiated thyroid cancer in patients treated by lobectomy? A systematic review and meta-analysis
  27. Cardiovascular Diseases
  28. The intra-individual variation of cardiac troponin I: the effects of sex, age, climatic season, and time between samples
  29. Infectious Diseases
  30. A cohort analysis of SARS-CoV-2 anti-spike protein receptor binding domain (RBD) IgG levels and neutralizing antibodies in fully vaccinated healthcare workers
  31. Patients with severe COVID-19 do not have elevated autoantibodies against common diagnostic autoantigens
  32. Cerebrospinal fluid markers of inflammation and brain injury in Lyme neuroborreliosis – a prospective follow-up study
  33. Letters to the Editors
  34. Misleading nomenclature of units of WHO materials used for standardization of SARS COv-2 serology
  35. Assessment of the humoral response in Omicron breakthrough cases in healthcare workers who received the BNT162b2 booster
  36. COVID-19 related mortality and religious denomination vs. genetics
  37. Unexpectedly low tacrolimus concentrations attributed to inappropriately labeled water container from the instrument manufacturer
  38. Effects of different pepsinogen cut offs in the screening of apparently healthy people
  39. Low levels of G17 and Barrett esophagus: a clinical relationship
  40. (In)direct chloride ISE measurements, room for improvement
  41. New concept of interactive academic poster used in medical scientific congress presented in the EuroMedLab 2021 Munich Session
Downloaded on 16.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2022-0191/html
Scroll to top button